Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Cadence Pharmaceuticals
Cadence Pharmaceuticals
(CADX)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Alesse
Ethinyl estradiol
,
Levonorgestrel
1997-03-27
2023-2039
Contraception
,
Breast neoplasms
,
Hot flashes
,
Hypogonadism
,
Menorrhagia
,
Premature menopause
,
Primary ovarian insufficiency
,
Prostatic neoplasms
Lo/ovral
Ethinyl estradiol
,
Norgestrel
1982-01-01
2023-2039
Contraception
,
Breast neoplasms
,
Hot flashes
,
Hypogonadism
,
Menorrhagia
,
Premature menopause
,
Primary ovarian insufficiency
,
Prostatic neoplasms
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Omiganan
infections
Sodium chloride
craniotomy
,
postoperative pain
,
morbid obesity
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use